EGFR biomarkers predict benefit from vandetanib in combination with docetaxel in a randomized phase III study of second-line treatment of patients with advanced non-small cell lung cancer.
about
Repositioning "old" drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion.EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment.KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib.Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases.Small molecule inhibitor regorafenib inhibits RET signaling in neuroblastoma cells and effectively suppresses tumor growth in vivo.Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients.Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer.
P2860
Q35942134-F3E1BE3E-D509-472D-AEA0-55EE06F8437EQ36772144-A9D82BB6-421E-492E-B211-A5ED886E5646Q36805595-BA476A9B-BD77-4073-BE18-68D317ACEFBFQ37204286-086A6B4B-A6F3-4F2C-8B46-91226FC0C949Q47123875-31D4D7F6-069D-46C1-8ADC-C9E73006328FQ47965726-1AD93A6E-4CB4-4E8B-BC4A-FBAAC81879EDQ54990183-B553A84E-B5F5-44E5-924F-19539B269C65
P2860
EGFR biomarkers predict benefit from vandetanib in combination with docetaxel in a randomized phase III study of second-line treatment of patients with advanced non-small cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
EGFR biomarkers predict benefi ...... ed non-small cell lung cancer.
@ast
EGFR biomarkers predict benefi ...... ed non-small cell lung cancer.
@en
EGFR biomarkers predict benefi ...... ed non-small cell lung cancer.
@nl
type
label
EGFR biomarkers predict benefi ...... ed non-small cell lung cancer.
@ast
EGFR biomarkers predict benefi ...... ed non-small cell lung cancer.
@en
EGFR biomarkers predict benefi ...... ed non-small cell lung cancer.
@nl
prefLabel
EGFR biomarkers predict benefi ...... ed non-small cell lung cancer.
@ast
EGFR biomarkers predict benefi ...... ed non-small cell lung cancer.
@en
EGFR biomarkers predict benefi ...... ed non-small cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
EGFR biomarkers predict benefi ...... ed non-small cell lung cancer.
@en
P2093
B E Johnson
J V Heymach
S J Lockwood
P2860
P304
P356
10.1093/ANNONC/MDU269
P577
2014-07-23T00:00:00Z